Survey: Fewer Than 1 in 3 Companies Ready for May 25 GDPR Deadline
The General Data Protection Regulation (GDPR) compliance deadline looms eight days away, but only 29 percent of companies will be ready, according to a new global survey conducted by ISACA. Conducted last month, ISACA’s GDPR Readiness Survey provides a near-real-time look at readiness levels, top compliance barriers and expected readiness timeframes.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180517005449/en/
Fewer than 1 in 3 companies say they'll be ready for the GDPR compliance deadline next week, according to new research from ISACA. (Graphic: Business Wire)
GDPR, a regulation out of the European Union, impacts entities doing business in or with the EU starting 25 May 2018. Not only are most unprepared for the deadline, but only around half of the companies surveyed (52 percent) expect to be compliant by end-of-year 2018, and 31 percent do not know when they will be fully compliant.
According to ISACA’s research, the top five challenges related to GDPR compliance are:
- Data discovery and mapping (59 percent)
- Prioritizing GDPR compliance among other business priorities (47 percent)
- Organizational education and change programs (45 percent)
- Ensuring cross-departmental collaboration and buy-in (42 percent)
- Preparation for data subject access or deletion requests (37 percent)
Cost was the seventh-highest concern, at 32 percent. About 27 percent say it will cost under US $1 million to become GDPR compliant, with 15 percent spending $1 million or more. More than half of the business technology professionals surveyed were unsure how much their organizations would be spending.
Among the survey’s most concerning findings is the level of employee education on GDPR and their role in compliance. Only 39 percent of respondents say their organizations’ employees have been educated to a satisfactory level about their responsibilities to maintain GDPR compliance.
“Employee awareness and education are critical components of ongoing GDPR compliance,” said Chris K. Dimitriadis, Ph.D., CISM, CRISC, CISA, past board chair of ISACA and chair of ISACA’s GDPR Working Group. “Awareness of—and commitment to—well-defined security, data management, and privacy policies and procedures clearly need to be an integral part of every organization’s culture, from the top down.”
The good news is that the majority of executive leaders recognize the importance of GDPR and its implications. According to the ISACA data, nearly 7 in 10 respondents (69 percent) believe their organization’s executives have made becoming GDPR-compliant a priority.
Organizations also expect to achieve significant benefits from GDPR compliance. The top three anticipated positive outcomes are:
- Greater data security (60 percent)
- Improved business reputation (49 percent)
- Marrying data security best practices with corporate culture (43 percent)
“One of the most practical and cost-effective ways organizations can support GDPR and other compliance requirements is to help employees understand the business value of the information they deal with on a regular basis,” said Tim Upton, CEO at TITUS, which sponsored ISACA’s survey and research report. “That way, employees become more aware of their responsibilities when it comes to handling and protecting data within the flow of work, providing added value to the ways organizations earn and maintain the trust of customers and employees.”
More information on the survey, including insights from GDPR experts, is available at www.isaca.org/gdpr-readiness-survey.
Nearing its 50th year, ISACA ® (isaca.org) is a global association helping individuals and enterprises achieve the positive potential of technology. ISACA equips professionals with the knowledge, credentials, education and community to advance their careers and transform their organizations.
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Zephyr Endobronchial Valves Improve Breathing, Quality of Life and Activity for Severe Emphysema Patients in US Pivotal Trial22.5.2018 20:19 | Tiedote
Pulmonx® Corp. today announced positive one-year results from the U.S. LIBERATE pivotal trial of the Zephyr® Endobronchial Valve, a minimally-invasive treatment for severe emphysema, an advanced form of chronic obstructive pulmonary disease (COPD). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180522006139/en/ Zephyr Endobronchial Valves (Photo: Business Wire) “The LIBERATE Study definitively proves that Zephyr Valves offer clinically meaningful improvements in three important areas for patients – the ability to breathe better, be more active, and enjoy an improved quality of life,” said the study’s lead investigator, Gerard Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University. He continued, “All primary and secondary endpoints were met, with Zephyr Valve treatment showing significant improvement for patients across multiple measures of breathing a
Seoul Semiconductor Announces the Availability of a Series of AC LED Modules22.5.2018 19:03 | Tiedote
Seoul Semiconductor, a leading global innovator of LED products and technology, announces a comprehensive series of AC LED modules that use the company’s patented Acrich AC LED technology. The modules are offered in designs from 200 to 10,000 lumens in round, rectangular and linear formats. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180522006054/en/ Seoul Semiconductor Announces the Availability of a Series of AC LED Modules (Photo: Business Wire) These AC modules integrate Seoul Semiconductor’s patented Acrich AC driver technology with the company’s advanced LEDs, enabling the design of compact light fixtures with superior lighting performance, making these modules ideal for a wide range of lighting applications. “Lighting designers who are looking to significantly reduce the size, weight, and volume of their luminaire designs can select one of our standard round, rectangular, or linear AC module designs to develop a co
Medicortex Finland Announces Agreement with Pro-Lab22.5.2018 16:58 | Tiedote
Medicortex Finland Oy announces that it has entered into an agreement with a Canadian company Pro-Lab Diagnostics Inc. Pro-Lab will be responsible for the regulatory process and registration of the ProbTBI™ brain injury detection kit in Canada and UK. Following a brain injury, the diagnostic test will detect in urine and saliva a unique brain injury biomarker which has been discovered and characterized by Medicortex. The agreement gives Pro-Lab exclusive rights for sales in the UK and Canada from which Medicortex will receive royalties. The agreement between the parties is confidential and no other details about the content of the agreement are disclosed. Pro-Lab will be responsible for the clinical validation of the kit prior to the commercial launch in the territories. In addition to the licensing agreement, the parties intend to initiate a development collaboration, the details of which are being discussed currently. “We are very proud that Pro-Lab Diagnostics has chosen to cooperat
ResMed Studies Show Remote Monitoring and Automated Resupply Improve Adherence to PAP Therapy22.5.2018 15:55 | Tiedote
Remote patient monitoring and resupply programs have been shown to improve patient adherence to positive airway pressure (PAP) therapy, according to two separate studies presented by ResMed (NYSE: RMD, ASX: RMD) this week at the ATS 2018 International Conference. Remote monitoring boosts compliance In the first study, medXcloud, a ResMed-assembled group of healthcare key opinion leaders, examined de-identified data of more than 2.6 million U.S. PAP users from ResMed’s world-leading remote monitoring network, AirView. Using this big data approach, researchers observed excellent adherence among patients initiating PAP therapy: 75 percent achieved the CMS compliance threshold.* This rate compares very favorably with that of non-cloud-connected PAP therapy and other chronic medical therapies – both around 50 percent. Plus, the large sample suggests that the findings are generalizable and likely to reflect real-world clinical care. Resupply program boosts long-term compliance In a separate
Asuragen to Launch the AmplideX® PCR/CE DMPK Kit and Present Growing Genetic Testing Portfolio at 2018 European Society of Human Genetics (ESHG) Conference22.5.2018 15:00 | Tiedote
Asuragen, Inc., a molecular diagnostics company delivering high-quality, easy to use products for complex testing in genetics and oncology, today announced the launch of the AmplideX® PCR/CE DMPK Kit* to simplify analysis of repeat expansions within the DMPK gene, which is implicated in myotonic dystrophy type I (DM1), also known as Steinert’s disease. DM1 is an inherited form of muscular dystrophy that affects the muscles as well as multiple other organ systems, and its severity is largely determined by the size of the CTG trinucleotide repeat expansion within the DMPK gene. These expansions commonly extend beyond a thousand CTG repeats and therefore have required the use of cumbersome Southern blot technology to estimate their size. “The AmplideX DMPK Kit represented a significant improvement over our existing process for analyzing large DMPK expansions,” said Doctor Sophie Rondeau, PharmD, PhD, and Professor Jean-Paul Bonnefont, MD, PhD, of the Necker-Enfants Malades Hospital in Par
Phil Brakewell Set to Lead WilsonHCG's Executive Search Efforts Across EMEA; Forbes Ranks WilsonHCG Among Best Executive Recruiting Firms22.5.2018 15:00 | Tiedote
WilsonHCG, global leader and premium provider of innovative talent solutions, further expands its Executive Search division with the appointment of Director Phil Brakewell. Phil, who brings more than 14 years of talent acquisition leadership experience and most recently served as Head of Executive Search for ResourceBank, will be responsible for leading WilsonHCG’s efforts in the EMEA region. Prior to joining ResourceBank, Phil held consultant and resourcing leadership positions at Hitchenor Wakeford and The Caudwell Group – where he was responsible for developing the business internationally and drove innovative search solutions on behalf of a diverse range of clients. “WilsonHCG’s reputation speaks for itself,” said Phil. “WilsonHCG tailors its key service offerings – including Executive Search – to suit individual client needs, and I am thrilled to be part of such a dedicated, innovative team. The new Director position, covering EMEA, demonstrates our commitment to both Executive Se
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme